Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

797 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.
Apostolou F, Gazi IF, Kostoula A, Tellis CC, Tselepis AD, Elisaf M, Liberopoulos EN. Apostolou F, et al. Among authors: Elisaf M. J Lipid Res. 2009 Dec;50(12):2532-9. doi: 10.1194/jlr.P900063-JLR200. Epub 2009 Jun 17. J Lipid Res. 2009. PMID: 19535817 Free PMC article. Clinical Trial.
High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment.
Christou GA, Tellis KC, Elisaf MC, Tselepis AD, Kiortsis DN. Christou GA, et al. Among authors: Elisaf MC. Hormones (Athens). 2012 Apr-Jun;11(2):178-88. doi: 10.14310/horm.2002.1345. Hormones (Athens). 2012. PMID: 22801564 Clinical Trial.
DESIGN: Thirty-seven obese or overweight [body mass index ≥27 Kg/m(2)], hypertriglyceridemic patients underwent one of the following interventions for 3 months: 1) Low-calorie diet (n=19), 2) Low-calorie diet plus fenofibrate (n=18). ...
DESIGN: Thirty-seven obese or overweight [body mass index ≥27 Kg/m(2)], hypertriglyceridemic patients underwent one of the following …
The predictive value of lipid markers in vascular disease.
Milionis HJ, Daskalopoulou SS, Elisaf M, Mikhailidis DP. Milionis HJ, et al. Among authors: Elisaf M. Curr Pharm Des. 2005;11(17):2209-24. doi: 10.2174/1381612054367409. Curr Pharm Des. 2005. PMID: 16026290 Review.
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.
Apostolou F, Gazi IF, Lagos K, Tellis CC, Tselepis AD, Liberopoulos EN, Elisaf M. Apostolou F, et al. Among authors: Elisaf M. Atherosclerosis. 2010 Oct;212(2):607-13. doi: 10.1016/j.atherosclerosis.2010.06.006. Epub 2010 Jun 11. Atherosclerosis. 2010. PMID: 20594556
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study.
Florentin M, Liberopoulos EN, Filippatos TD, Kostara C, Tselepis A, Mikhailidis DP, Elisaf M. Florentin M, et al. Among authors: Elisaf M. Expert Opin Pharmacother. 2008 Nov;9(16):2741-50. doi: 10.1517/14656566.9.16.2741. Expert Opin Pharmacother. 2008. PMID: 18937609 Clinical Trial.
Effects of evolving lipid-lowering drugs on carbohydrate metabolism.
Tsimihodimos V, Elisaf M. Tsimihodimos V, et al. Among authors: Elisaf M. Diabetes Res Clin Pract. 2018 Mar;137:1-9. doi: 10.1016/j.diabres.2017.12.012. Epub 2017 Dec 24. Diabetes Res Clin Pract. 2018. PMID: 29278710 Review.
797 results
Jump to page
Feedback